Reply to Paul and Leibovici
- PMID: 35818902
- DOI: 10.1093/cid/ciac415
Reply to Paul and Leibovici
Conflict of interest statement
Potential conflicts of interest. G. R.-Y. has received a research grant from Pfizer and has been a scientific consultant for Teva and Merck; has received payment or honoraria from MSD regarding the COVID pandemic, unrelated to the topic of the study; and has participated on Data Safety Monitoring Boards or Advisory Boards for Moderna and AstraZeneca. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
Bacteremic Pneumococcal Pneumonia.Clin Infect Dis. 2022 Oct 12;75(8):1484. doi: 10.1093/cid/ciac414. Clin Infect Dis. 2022. PMID: 35818903 No abstract available.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources